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 Small amounts of freshwater fish had no impact on infants’ n-3 LCPUFA status 
 Fish-based foods reduced n-6 PUFA and n-6/n-3 PUFA ratio in non-breastfed infants 
 Late cessation of breastfeeding positively correlated with infants’ n-3 LCPUFA  
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 n-3 LCPUFA are essential for visual and cognitive development. 
 Breast milk and marine fish are recommended sources of n-3 LCPUFA for children.  
 Freshwater fish is the dominant source of n-3 LCPUFA in landlocked or riparian 
regions, but contain lower amounts of n-3 LCPUFA compared to marine fish.  
 Complementary food products containing 10-12% percent freshwater fish by dry-
weight for nine months yielded a maximum intake of 86.5 mg/day n-3 LCPUFA in 
six-month-old Cambodian infants. 
 Fish-based complementary food had no impact on infants’ whole blood n-3 LCPUFA 
compared to foods without fish.  
 The lack of impact of freshwater fish consumption on infant whole blood n-3 
LCPUFA status could be due to low content of n-3 LCPUFA and a high intake of n-3 





The n-3 LCPUFA are essential for visual and cognitive functions of infants and children [1], 
but humans have a limited endogenous conversion of α-linolenic acid (ALA, 18:3 n-3) to n-3 
LCPUFA [2]. Breast milk and dietary fish are recommended as key sources of n-3 long-chain 














has a relatively high content of n-3 LCFUFA and arachidonic acid (AA, 20:4 n-6) and when 
the rate of breastfeeding decreases, dietary n-3 LCPUFA plays an important role in 
maintaining n-3 LCPUFA supply to ensure optimal DHA incorporation into the growing 
brain.  
 
There are only a few studies on the effect of dietary n-3 LCPUFA in infants and young 
children in developing countries and poor communities [4]. Cambodia ranks among the 
poorest countries in the world with high prevalence of undernutrition [5]. Situated in the 
Mekong River basin, Cambodia has a productive freshwater environment and a variety of 
several hundred freshwater fish species which is important in the traditional diet [6]. The 
majority of Cambodian population consume fish at least once a day, making it the most 
consumed animal source food [7]. National consumption of freshwater fish in Cambodia was 
more than the consumption of all other animal source food combined, and about five times the 
consumption of marine fish [8]. The traditional complementary food in Cambodia is a rice 
porridge (borbor) served plain or with a small amount of non-staple foods (vegetables, fish, 
egg etc).  However, a study in 6-12 month-old Cambodian children indicates that overall fish 
intake among infants is low, even if the frequency may be high showed that (only 3-23 g, with 
maximum serving frequency of 3 times per week) [9]. The prevalence of breastfeeding in 
Cambodia is generally high, with a median duration of breastfeeding was 16 months, but less 
than 40% of 18-23 months old children were still breastfed [5]. Furthermore, low 
consumption of marine fish [8] possibly limit the breast milk content of n-3 LCPUFA.  
 
While all fish contain some n-3 LCPUFA, fish species from warm freshwater environments 
generally have considerably less docosahexaenoic acid (DHA, 22:6 n-3) and eicosapentaenoic 














nutritional contribution of n-3 LCPUFA from freshwater fish uncertain [10-14]. Without 
taking into account these differences, Cambodian was estimated to have high intake of n-3 
LCPUFA [15, 16]. Due to the important role of n-3 LCPUFA in infant development, it is very 
relevant from a public health perspective to examine to what extent locally available 
freshwater fish can improve the n-3 LCPUFA status among infants and young children in 
riparian regions. There are currently no studies that have investigated the efficacy of small 
amounts of dietary freshwater fish in improving n-3 LCPUFA status, performed in infants and 
young children in a developing country with restricted access to marine fish. 
 
Therefore, the aim of the present study was to examine document the general fatty acid status 
and investigate the impact of daily consumption of small amounts of freshwater fish-based 
complementary food on whole blood n-3 LCPUFA in Cambodian infants from 6 to 15 
months, living in the landlocked and riparian province of Prey Veng. The study is important to 
provide evidence for dietary recommendations and potential benefits of freshwater fish 
consumption for fatty acid status of infants and young children in landlocked or riparian 
regions of developing low-income countries. 
 
Breast milk and dietary fish are recommended as key sources of n-3 long-chain 
polyunsaturated fatty acids (n-3 LCPUFA) for children under 2 years of age [1]. However, 
fish species from warm freshwater environments generally have less docosahexaenoic acid 
(DHA, 22:6 n-3) and eicosapentaenoic acid (EPA, 20:5n-3) compared to cold-water species 
from marine environments [2-4]. Hence, the status of n-3 LCPUFA in infants and children 
under 2 years of age beyond the breastfeeding period with restricted access to marine food 















n-3 LCPUFA are essential for visual and cognitive functions of infants and children [5], but 
humans have a limited endogenous conversion of α-linolenic acid (ALA, 18:3 n-3) to n-3 
LCPUFA [6]. Breast milk has a relatively high content of n-3 LCFUFA and arachidonic acid 
(AA, 20:4 n-6) and when the rate of breastfeeding decreases, dietary n-3 LCPUFA plays an 
important role in maintaining n-3 LCPUFA supply to ensure optimal DHA incorporation into 
the growing brain. 
 
Studies on children’s n-3 LCPUFA status and the efficacy of fish consumption as well as fish 
oil supplementation have mainly been conducted in developed country settings. Breastfeeding 
aside, children in communities of landlocked or riparian regions, are likely to rely on 
freshwater fish as the main source of n-3 LCPUFA [9]. The contribution of n-3 LCPUFA 
from freshwater fish to human diet is uncertain [2-4, 10, 11].  
 
The important role of n-3 LCPUFA in development and the uncertain contribution of 
freshwater fish as the dominant source of n-3 LCPUFA in landlocked or riparian regions, 
raises the question about the n-3 LCPUFA status among infants and young children living in 
such environments beyond the exclusive breastfeeding period. No studies on the efficacy of 
small amounts of freshwater fish consumption in improving n-3 LCPUFA status have 
previously been performed in infants and young children in a developing country with 
restricted access to marine fish.  
 
2. MATERIALS AND METHODS 
 
2.1. Study design and setting 
This study was part of the ‘WinFood study’ in Cambodia [17]. The WinFood study was an 














impact of four complementary food products on body composition and iron status in 
Cambodian infants. Whole blood fatty acid was a secondary outcome. The study was designed 
primarily to assess the efficacy of locally developed complementary foods on child growth 
including body composition, micronutrient status, and gross motor development, in 
comparison with standard food aid products [18]. Whole blood fatty acid was also analysed as 
secondary outcome and is the focus of the current sub-study. The study was conducted from 
March 2011 until March 2012 in seven communes in the Prey Veng province, Cambodia.  
 
Infants were recruited at 6 months (±2 weeks) of age as described in detail elsewhere [12]. 
and unless dropped out, completed at 15 months (±2 weeks) as described in detail elsewhere 
[17]. Infants with severe acute malnutrition defined as weight-for-length z-score (WLZ) ≤-3 
or pitting oedema, clinical signs of vitamin A deficiency, and/or severe anaemia were 
excluded from the study. Infants with persistent diarrhoea were also excluded from the study 
and were given offered ORS treatment and re-invited in 2-4 weeks. More details regarding the 
study participants are available elsewhere [17].  
 
This study was conducted according to the guidelines laid down in the Declaration of Helsinki 
and all procedures involving human subjects/patients were approved by The National Ethics 
Committee for Health Research, Ministry of Health, the Royal Government of Cambodia. This 
trial was registered at controlled-trials.com as ISRCTN19918531 at 
http://www.isrctn.com/ISRCTN19918531.  
 
2.2. Intervention food products 
The WinFood products in Cambodia were developed with a broad aim of assessing food-














The WinFood project involved identification of traditional foods with the potential to be used 
in complementary foods; formulation and optimization of the complementary foods; and 
palatability and acceptability assessment among mothers and infants [18]. The amount of 
animal source food added into the formula was limited by the aim to not pronouncedly 
exceeding the recommended upper level of the safe protein intake for infants and children age 
up to 1 year old, which was 14.8 gram/day [19]. The amount of total fat in the formula was 
technologically also limited to maximum 10%. The current study tests the efficacy of the 
formulated complementary food with respect to their ability to increase n-3 LCPUFA fatty 
acid status in the infants. 
 
At the baseline visit, the infants were randomized to one of four intervention groups; 
WinFood (WF) complementary food made of rice with local small freshwater fish species and 
edible spiders; WinFood-L (WF-L) made of rice with local small freshwater fish of mixed 
species; CSB+, a fortified standard corn-soy blend product used by the World Food 
Programme (WFP) with sunflower oil distributed separately to be added at preparation 
(following standard WFP procedures for CSB+); and CSB++, a standard fortified corn-soy 
blend product with dried skimmed milk and soya oil, used by WFP.  
 
The intervention foods were distributed in sachets of daily rations, adjusted for age of the 
child. The sachets had identical WinFood logos with cooking instructions. The intervention 
lasted for nine months, during which the caregivers were provided with a batch of daily 
rations of food until the next scheduled follow-up. Local health staff in each village visited the 















The fat and fatty acid content of the intervention food were estimated, based on the fat and 
fatty acid content of the food components obtained from laboratory analyses (for fish and 
spider) and food composition data [20] (for all other food materials). The maximum fatty acid 
intake was calculated from the estimated maximum intake of the intervention food. Detailed 
information on the food composition, fat content and fatty acid composition of the 
intervention foods is shown in Table 1. 
 
2.3. Intake calculation 
Food consumption was estimated from the food sachets returned at the monthly follow-up 
visit. All caregivers at all visits reported that the distributed foods had been eaten only by the 
infant and not shared with the household. The empty, partially empty and unopened sachets 
were collected and weighed to estimate the amount of food consumed every month. We did 
not collect any information about food waste, thus do not have information about the actual 
take of the intervention products. Hence, we can only estimate the maximum intake. The total 
fat content of the intervention foods was obtained from laboratory analyses. The fatty acid 
contents were calculated from the fatty acid composition of the different food ingredients, 
which was based on analyses for fish (Esomus longimanus, Paralauba typus and mixed 
batches of common indigenous small fish), spider (Haplopelma species) and database 
information (frida.fooddata.dk [20]) for the remaining ingredients. This information was used 
to calculate the maximum intake of fat and fatty acid.  The estimates do not include plate 
waste and as such are an estimate of maximum intake. The fat and fatty acid content of the 
intervention foods were obtained from laboratory analyses. 
 
The contribution of energy from the consumption of consumed intervention foods to the 














was estimated to be 6.8–10.9% (Table 2), based on a total daily energy requirement of 682 
kcal/day in the age 6-8 months, 830 kcal/day for 9-11 month-old infants and 1,092 kcal/day 
for children from 1-2 years of age [21]. The maximum fatty acid intake was calculated from 
the estimated maximum intake of the intervention food and fatty acid composition of the 
intervention food.  
 
2.4.  Blood sampling 
Blood samples were collected at baseline and endline. Blood samples were collected by 
trained local nurses in vacutainers containing heparin and shaken at least eight times to avoid 
coagulation. Aliquots of blood (500 µL), were pipetted into 1.5 mL-tubes containing 50 µL of 
0.1% butylated hydroxytoluene in ethanol for fatty acid analysis. The tubes were quickly 
covered and stored in a -20°C freezer. After the completion of a sampling round in the field 
(3-5 days), frozen samples were transported (1-2 hours) to the Department of Fisheries Post-
harvest Technologies and Quality Control in Phnom Penh and stored at -20°C until shipment 
to the laboratory of the University of Waterloo, Canada for analysis. In Canada, the samples 
were stored at -75°C until immediately before analysis. Storage time in the field prior to 
arrival in Canada ranged from 4-6 months and total storage period before analysis varied from 
9 to 11 months. An assessment of LCPUFA stability during storage and more details about the 
blood sampling procedures are available in [22].  
 
2.5. Fatty acid analysis 
The whole blood fatty acid concentrations were determined in 50 µL of thawed blood that was 
trans-esterified by addition of 1 mL 14% boron trifluoride in methanol, 300 µL hexane 
containing 50 µg/mL BHT and 33.33 µg/mL 22:3N-3 ethyl ester (internal standard, Nu-














organic and aqueous layers were separated after the addition of 1 mL hexane and 1 mL water, 
and centrifugation at 1750 g for 5 minutes. The upper organic hexane layer, containing the 
fatty acid methyl esters, was collected, fully dried under a stream of nitrogen gas, 
reconstituted into 65 µL of hexane and stored in vials until analysis by gas chromatography. 
More details of the fatty acid analysis of the whole blood method is available in [22].  
 
Fatty acid methyl esters were separated using a Varian 3900 gas chromatograph equipped 
with a DB-FFAP capillary column of 15 m x 0.10 mm with a 0.10 µm film of 
nitroterephthalic acid modified polyethylene glycol (J & W Scientific, Agilent Technologies, 
Mississauga, ON) with hydrogen as the carrier gas [25, 26]. The fatty acid composition data 
are expressed both quantitatively (concentrations in µg/dL) and qualitatively (relative % of all 
fatty acids by weight (FA%)). 
 
2.6. Statistical analysis 
Anthropometric data were double entered in Epidata version 3.1 (The EpiData Association). 
All analyses were performed by SPSS (Version 20.0.0, IBM Corp., Kgs. Lyngby, Denmark). 
Significance was declared for p<0.05.  
 
Participants’ baseline characteristics and quantitative values for individual fatty acids and 
fatty acid groups were described using mean (±SD) or count (%). For intake of fatty acids, 
data were analysed by athe Kruskal Wallis non-parametric test. The effect of the intervention 
on individual fatty acids and fatty acid groups was evaluated by means of analysis of 
covariance (ANCOVA) models that included adjustment for baseline outcome values, 
baseline plasma CRP, age (months), sex, age of the child (months) when breastfeeding was 














breastfeeding in the last 24 hours at endline. Model assumptions were assessed visually using 
residuals. Outcomes were transformed where when needed. Results wereare reported as 
unadjusted mean (±SD). Additionally, similar analyses were carried out based on food groups 
being combined as fish-based (WF and WF-L) and the non-fish-based (CSB+ and CSB++) 
intervention foods. Likewise, similar analyses stratified according to infants being breastfed or 
non-breastfed, was carried out. A subgroup analysis comparing the fish-based group with 
CSB+ and CSB++ was also carried out. 
 
Furthermore, the interaction between treatment and breastfeeding status was investigated by 
inclusion of the interaction term in the ANCOVA analyses. Subsequently, we conducted a 
stratified analyses analysis in infants who breastfed in the last 24 hours prior to blood 
sampling at endline (breastfed group) and those who were not (non-breastfed group) were 
conducted. Finally, Pearson correlation coefficients were used for exploring the association 




3.1. Participants’ Baseline characteristics 
Of the 514 invited infants, 440 (85.6%) were screened and 419 (95.2%) of these met the 
inclusion criteria and were randomly allocated to one of the four food groups. Blood was 
successfully sampled from 389 (92.8%) at baseline and 341 (81.4%) at endline, resulting in 
315 (75.2%) with a complete pair of blood samples (see flow diagram in Figure 1). The 
intervention groups were similar in age, anthropometric status, breastfeeding status, social 
economic status, serum CRP, as well as whole blood fatty acid composition at baseline (Table 
2). There was more household in the CSB groups whose primary income was fishery (6 for 














household in WF group whose primary income was labouring work (18 vs 9, 7 and 15 in WF-
L, CSB++ and CSB+ groups, respectively). Furthermore, there were more wasted infants in 
CSB+ group than in any other groups (7 vs 5, 2, and 4 infants in CSB++, WF and WF-L 
groups, respectively) and more stunted infants in CSB+ group than in any other groups (22 vs 
14, 13 and 13 infants in CSB++, WF and WF-L groups, respectively).  
 
3.2.  Consumption of intervention foods 
A total of 79 participants did not consume any of the provided food during the 9 months, for 
various reasons. The monthly consumption of the complementary food during the 9 months of 
intervention did not differ between the four food groups. Infants in the fish-based groups 
consumed 67% of the provided food, whereas infants in the non-fish-based group consumed 
65%. The mean ± SD of total consumption of fish-based intervention food during the course 
of 9 months, was 15.1 ± 6.4 kg and that of the non-fish-based foods were 14.6 ± 6.5 kg 
(p=0.515).  
 
3.3. Energy intake from intervention food 
The additional supplementation with fat in CSB+ (the sunflower oil was distributed in 
separate sachet following WFP standard practise) resulted in higher calculated mean ± SD 
intake of energy from fat in the non-fish-based intervention foods groups (CSB+ and CSB++ 
pooled) than in the fish-based intervention food groups: 55.8 ± 27.0 vs 44.1 ± 18.9 kcal/day, 
p<0.001). Subsequently, assuming the distributed oil was administered as prescribed in the 
CSB+ group. Consequently, it resulted in higher energy contribution of from fat to the daily 
energy requirement than in the other intervention groups (Table 2). 
 














The estimated intake of various fatty acids from the intervention foods differed among the 
food groups (Table 2). There was no or negligible intake of n-3 LCPUFA from the 
consumption of non-fish-based intervention foods, in comparison to 22.1 ± 11.1 mg/day EPA, 
16.8 ± 7.1 mg/day DPA and 47.6 ± 20.5 mg/day DHA, from the fish-based complementary 
foods. The fish-based and non-fish-based groups also differed in intake of AA from the 
interventions foods (mean ±SD) of 44.2 ± 22.3 mg/day vs essentially zero. 
 
3.5.  Effect of intervention on whole blood n-3 LCPUFA 
There was no difference in whole blood fatty acid composition between the infants in the WF, 
WF-L, CSB++ or CSB+ groups after 9 months intervention (Table 4). Furthermore, there was 
no difference in whole blood fatty acid profiles or n-3 LCPUFA percent, when the fish-based 
(WF and WF-L) and the non-fish-based (CSB+ and CSB++) intervention foods were 
combined. Similar results were also found when comparing fish-based group with CSB+ and 
CSB++ separately (results are not shown in table or figure).  
 
3.6. Effect of intervention on whole blood PUFA stratified by endline breastfeeding status   
Breastfeeding status decreased from 98.3% of the infants being breastfed at baseline to 77.9% 
at the end of the 9 months intervention. Those who were not breastfed at endline, had on 
average stopped breastfeeding at mean (± SD) age of 13.1 ± 2.8 mo. Both the breastfed infants 
and those who were no longer breastfed at endline, had started receiving solid foods from 5.3 
mo of age (5.3 ± 1.5 vs 5.3 ± 1.3 mo).  
 
The fatty acid composition at endline differed significantly between the infants who were still 
breastfed and those who had stopped, except for ALA and linoleic acid (LA, 18:2n-6) (Table 














higher among breastfed infants and the ratio of n-6 to n-3 PUFA was lower. There was an 
interaction between complementary food received, and breastfeeding for the n-6/n-3 PUFA 
ratio (p=0.026), corresponding to a lower level in the fish-based intervention groups compared 
to the non-fish-based groups (7.1 ± 1.2 vs 7.9 ± 1.8) among the subsample of infants who had 
stopped breastfeeding. There was also an interaction (p=0.003) between breastfeeding and 
intervention products for n-6 PUFA, which among the breastfed infants tended to be lower in 
the non-fish-based groups compared to the fish-based groups (26.6 ± 2.4 vs 27.0 ± 2.1 FA%, 
p=0.069), but conversely tended to be lowest in the fish-based group among the non-breastfed 
infants (24.2 ± 3.5 vs 25.4 ± 3.8 FA%, p=0.092). 
 
3.7. Association between age when breastfeeding stopped and n-3 LCPUFA status 
Age of child when breastfeeding stopped (months) was strongly correlated with endline DHA 
(r=0.489, p<0.001) and with the change from baseline to endline in the percentage of whole 
blood DHA (r=0.277, p<0.001). It also correlated with relative percentages of EPA and DPA 
at endline (r=0.288, p<0.001 and r=0.125, p=0.021 respectively), and changes in EPA and 
DPA from baseline to endline (r=0.145, p=0.010 and r=0.122, p=0.030 respectively). Intake 
of EPA, DPA and DHA waswere not correlated with the changes or the endline FA% of the 
corresponding fatty acids.  
 
4. DISCUSSION AND CONCLUSIONS 
 
4.1. Discussion 
The results of our study showed no overall effect of consumption of complementary foods 
containing small amounts of freshwater fish for nine months on whole blood fatty acid 
composition in Cambodian infants. The lack of effect of freshwater fish consumption on n-3 














intervention foods was modified by breastfeeding and that the fish-based complementary 
foods reduced n-6 PUFA and the n-6/n-3 PUFA ratio in infants who were not breastfed 
stopped breastfeeding at endline.  
 
Furthermore, bivariate correlation showed no association between n-3 LCPUFA status of the 
infants and intake of n-3 LCPUFA, but age at cessation of breastfeeding was strongly 
correlated with endline whole blood n-3 LCPUFA. This indicates These findings suggest this 
results indicate that prolonged breastfeeding played a more important role for the n-3 
LCPUFA status of the infants, than the n-3 LCPUFA intake from the intervention foods.  
 
Breastfeeding is nearly universal in Cambodia [5], and the majority of the infants in the 
current study were breastfed during the intervention period. The exclusive breastfeeding rate 
was higher in the study area than in the national data. More than 87% of the children were still 
exclusively breastfed at 5 months old, and the median duration of exclusive breastfeeding was 
6 months (compared to 50.9% and 4 months in the overall population) [5] and 78% of the 
children in this study was still partially breastfed at the end of the intervention. A recent study 
on fatty acid composition of breast milk from Cambodian mothers has been reported to be 
higher in DHA (0.40%) and AA (0.68%  [30], compared to the world wide average content of 
0.32 FA% DHA and 0.47 FA% AA [31]. Assuming the breast milk intake of the Cambodian 
infants was ranging between 516-875 ml/day [32], daily breastfeeding alone contributed to an 
intake of 89-151 mg/day of n-3 LCPUFA, which is around 1-1.5 times more than the 
maximum contribution of n-3 LCPUFA from the fish-based intervention food (87 mg/day).  
 
Breastfeeding has been associated with higher whole blood EPA and DHA as well as higher 














and this is in agreement with what we found in the current study. Breastfeeding was found to 
modify the effect of the intervention, as the ratio of n-6/n-3 PUFA was lower after 
intervention with the fish-based product than after intervention with the non-fish-based in the 
sub-group of non-breastfed infants only. This indicates that the high breastfeeding rate could 
have blurred the effect of the intervention. This is supported by a randomized study in which 
consumption of both DHA-enriched eggs (180 mg/day DHA) and regular eggs (40 mg/day 
DHA) for 6 months improved erythrocyte DHA among 6 months-old non-breastfed infants, 
whereas only the enriched eggs improved DHA in the breastfed infants [34]. Another study on 
neonates  also reported a stronger influence of breast milk on infant erythrocyte DHA status, 
than six -months supplementation with fish -oil capsules which supplied 250-280 mg/day of 
DHA, which was nearly three times that of the breast milk [35].  The supplementation resulted 
in the erythrocyte DHA which was only 0.6 FA% higher than in the placebo group [29].  
 
While the primary outcomes reported from this study indicated that small fish may be an 
affordable alternative to cow milk in complementary food products [17], for this secondary 
outcome, the intervention foods formulation was not designed to meet the n-3 LCPUFA 
recommendation. The WinFood product formulation, was based on balancing protein intake 
from Cambodian animal source foods and micronutrients. The low content of n-3 LCPUFA in 
WF and WF-L is due the result of to; 1) technologically limited fat content in the products, 2) 
the limitation of how much animal source food can be added to provide the desired level of 
total protein, and 3) combined with the relatively low content of n-3 LCPUFA in the 
freshwater fish. With a total fat content of only 10% and the addition of tropical freshwater 
fish to the WF and WF-L products that gave rise to an n-3 LCPUFA content of around 1.6 
FA%, thus resulting in an estimated daily intake of n-3 LCPUFA of 87 mg/day. Intakes of n-3 














composition. An observational study in pre-school South African children from urban and 
rural areas, did not detect any difference in erythrocyte n-3 LCPUFA despite a significantly 
higher intake of EPA (20 mg/day) and DHA (32 mg/day) in the children from the urban 
compared to the rural areas (1 and 2 mg/day, respectively) [27]. Supplementation of school-
age (6-10 years) children in Australia and Indonesia with a daily dose of 88 mg of DHA and 
20 mg of EPA for 12 months did result in higher plasma DHA in both countries, but did not 
affect plasma EPA in the Indonesian children [28].  
 
Whole blood DHA in the breastfed Cambodian infants at the beginning of the study was 
relatively high, compared to their peers from developed countries high-income countries, even 
for infants who were no longer breastfed at endline. At 15 months of age, the whole blood 
fatty acid composition of infants in this study was similar to that observed in Cambodian 
infants in a study by Agostoni et al. [36] with a breastfeeding rate of 99% (online 
supplementary table 1). In both studies, Cambodian infants had higher DHA, AA, and total 
PUFA as well as an increased ratio of DHA to ALA, compared to Italian or Danish infants of 
similar age. Even the Cambodian infants in this study who were no longer breastfed at 
endline, had high DHA, EPA, and n-6/n-3 PUFA ratio compared to Danish and Italian infants. 
The good n-3 LCPUFA status of the Cambodian infants could indicate that n-3 LCPUFA-rich 
complementary foods may not be of great importance to ensure a good n-3 LCPUFA status in 
this population.  This could be due to the extended breastfeeding practice, and or, could also 
be due to differences in the overall diet in the Cambodian settings relative to that in Europe, 
e.g. the overall intake of fat. As freshwater fish remains a significant dietary source in this 
population, it is worth investigating in future studies if the contribution of n-3 LCPUFA from 
freshwater fish to the Cambodian infants is more efficient when channelled through their 















The lack of an overall effect of the freshwater fish-based complementary foods on n-3 
LCPUFA in these mostly breastfed infants could be due to the low supply of n-3 LCPUFA 
from the fish-based intervention foods. The low content of n-3 LCPUFA in WF and WF-L is 
due to a technologically limited fat content in the products, combined with the relatively low 
content of n-3 LCPUFA in the freshwater fish. The fat content in the fish-based intervention 
food was only around 10%. With addition of the tropical freshwater fish, the n-3 LCPUFA 
content in the WF and WF-L product was around 1.6 FA% giving rise to an estimated daily 
intake of n-3 LCPUFA from the WinFood fish-based products of 86.5 mg/day, which is 
equivalent to the intake from 6 g of raw wild Atlantic salmon, 37 g of cod [20].  
 
Other studies have also reported an absence of an effect of similar intakes of n-3 LCPUFA on 
blood fatty acid composition. No difference in erythrocyte n-3 LCPUFA was observed 
between 3.6 year-old South African children from urban and rural areas, despite a 
significantly higher intake of EPA (20 mg/day) and DHA (32 mg/day) in the children of the 
urban compared to the rural areas (1 and 2 mg/day, respectively) [27]. Supplementation of 
school-age (6-10 years) children in Australia and Indonesia with a daily dose of 88 mg of 
DHA and 20 mg of EPA for 12 months did result in higher plasma DHA in both countries, but 
did not affect plasma EPA in Indonesian children [28]. supplementation of 6 month-old 
infants with 180 vs 40 mg/d of DHA from eggs for 6 months only resulted in a difference in 
erythrocyte DHA of  0.6 FA% [29].  
This is supported by a study that found strong correlation between infant erythrocytes DHA 
and breastmilk DHA even in the presence of infant supplementation with a high doses of n-3 
LCPUFA [23]. Breastfeeding is nearly universal in Cambodia, with 96% breastfeeding of the 














[24]. The majority of the infants in the current study were breastfed during the intervention 
period.  
 
Breastfeeding was associated with higher whole blood EPA and DHA as well as higher AA 
and total PUFA and a lower n-6/n-3 PUFA ratio compared to the non-breastfed infants [25]. 
Furthermore, breastfeeding was found to modify the effect of the intervention. Among the 
sub-group of non-breastfed infants, the infants in fish-based intervention groups had a lower 
ratio of n-6/n-3 PUFA compared to the infants in the CSB food groups. This indicates that the 
high breastfeeding rate could have blurred the effect of the intervention. This is supported by 
a randomized study in which consumption of both DHA-enriched eggs (180 mg/day DHA) 
and regular eggs (40 mg/day DHA) for 6 months improved erythrocyte DHA among 6 
months-old non-breastfed infants, whereas only the enriched eggs improved DHA in the 
breastfed infants[26].  
 
4.2. Strengths and limitations  
To our knowledge, this study is the first randomized intervention study analysing the impact 
of freshwater fish consumption on n-3 LCPUFA status of infants. The result showed lack of 
impact on n-3 LCPUFA status from small amounts of freshwater fish in processed 
complementary food products, in infants with a high frequency of breastfeeding. The result 
provides the first evidence on the absence of n-3 LCPUFA benefit from small amounts of 
freshwater fish in complementary foods for infant and young children. The results support the 
importance of continued emphasis on the benefits of continuing breastfeeding in dietary 
recommendations for infants and young children. The result can contribute to dietary 
recommendation for infants and young children. The validity of the data results in this study, 














Cambodian infants [36] differences in fatty acid composition of breastfed compared to non-
breastfed [37], and differences in fatty acid composition of boys and girls (online 
supplementary table 2) [38, 39]. Furthermore, the observed endline values of whole blood 
DHA+EPA closely match predicted value based on the daily intake of EPA+DHA and the 
equation by Patterson et al. (actual values for the fish-based and non-fish-based groups 
3.43±0.79 and 3.41±0.80 FA%, respectively, vs predicted values 2.93±0.10 vs 2.70±0.03 
FA%, respectively). With 300 infants, we should have a power of around 0.75 to detect the 
predicted difference (0.23 FA% - i.e. around 0.3 SD), so the fact that we do not see this 
difference could indicate that we overestimated the intake. 
 
Although, there are some limitations in our study Unfortunately, we posit that they do were 
not diminishable to assess the validity actual intake of the results. The design is limited by 
intervention products and thus, do not know the lack exact n-3 LCPUFA intake. However, the 
observed endline values of direct assessment of fatty acid intake from other whole blood 
DHA+EPA closely match predicted value based on the estimated daily intake of EPA+DHA 
from the intervention food and breast milk [30, 32] and the equation by Patterson et al., [40]. 
breast milk consumption, but the use of randomization should have ensured that consumptions 
was homogeneous in the fish-based and non-fish-based groups. Our study could have 
benefited from the use of erythrocyte fatty acid measurement, which best better reflects a the 
long-term accumulation of LCPUFA.n-3 LCPUFA intake and thus could have given a more 
precise measure of intake during the intervention. Nevertheless, whole blood fatty acid 
sampling was practically more feasible under the field condition and provides a balanced 















The study design is limited by being a secondary outcome of an intervention in which the 
intervention foods were not formulated to fulfill the n-3 LCPUFA requirements, and we did 
not make direct assessment of the fatty acid intake from other foods and breast milk 
consumption was not directly assessed. However, the strength of the randomization should 
have ensured that consumptions were homogeneous in the fish-based and non-fish-based 
groups. Shelf life was not measured, but preclusion was taken by producing the food within 
one to three months before distribution, to assure that all intervention foods were consumed 
within six months of production (or changed with the products from new batch). This 
diminish the risk for contamination or degradation.  
 
Additionally, differences in number of infants who were stunted, wasted and whose family 
income was generated from fishery were relatively small and thus, would not be expected to 
have an impact on the results of the study. However, a Apart from the differences in fish in 
the complementary foods, three of the products (CSB++ and CSB+, and WF-L) were also 
provided micronutrient, which fortified with micronutrients. Some of these, might have 
improved the infants’ fatty acidn-3 LCPUFA status, and reduced the effect of n-3 LCPUFA 
intake from fish-based intervention foods, as micronutrient supplementation has been shown 
to affect n-3 LCPUFA PUFA status [21, 27][28, 36] by a yet unknown mechanism.  
 
4.3. Conclusions 
In conclusion, daily consumption of complementary foods food products with 10-12% local 
freshwater fish for 9 months by largely breastfed infants resulted in an estimated maximal 
intake of up to 86.587 mg/day of n-3 LCPUFA, additional in addition to the intake from 
breast milk and other sources. The inclusion of the small amounts of freshwater fish in the 














of largely breastfed infants. The , but the n-6/n-3 PUFA ratio was reduced among the non-
breastfed infants. The overall whole blood PUFA profile of the Cambodian infants in this 
study was comparable to or better than infants in more affluent high-income countries, 
presumably due to the high rate of prolonged breastfeeding. Thus, This indicates that 
supplementation with n-3 LCPUFA in this population may not be necessary as long as the 
breastfeeding rate is high. Further, but studies of the effect of freshwater fish on n-3 LCPUFA 
status in communities with lower breastfeeding rate could clarify the amount of fish needed to 
achieve potential developmental benefits. benefits. It is noted that breastfeeding practices 
were not compromised by the intervention and despite of the lack of pronounced effect on n-3 
LCPUFA status of largely breastfed children, early introduction of complementary food with 
local fish will contribute to food diversification and benefits beyond the breastfeeding stage.  
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WF WF-L CSB++ CSB+ 
Energy
 
(kcal) 474 428 458 482 
Carbohydrate (g) 79.9 73.7 73.6 69.9 
Protein
2 
(g) 15.4 12.6 16.8 14.6 
Fat
3
 (g) 9.8 8.7 9.6 14.5 
Fat contributed from (g)
3
: 
    
Rice, white, milled 1.26 1.15 - - 
Fish, Esomus longimanus 1.22 - - - 
Fish, Paralaubuca typus 2.27 - - - 
Spider, Haplopelma species 0.24 - - - 
Mixed small fish species - 2.71 - - 
Soya oil 4.80 4.80 3.00 - 
Sunflower oil - - - 8.50 
Maize (white or yellow) - - 1.83 2.05 
Dehulled soya (flour) - - 4.68 - 
Whole soya - - - 3.96 




    
SFA 2.45 2.08 1.38 1.68 
MUFA 2.37 1.93 2.26 3.31 
PUFA 3.96 3.85 5.25 8.41 
n-6 PUFA 3.32 3.19 4.67 8.11 
LA (18:2n-6) 3.14 3.06 4.67 8.11 
AA (20:4n-6) 0.11 0.07 0.00 0.00 
n-3 PUFA 0.63 0.64 0.56 0.31 
ALA (18:3n-3) 0.44 0.47 0.56 0.31 
EPA (20:5n-3) 0.06 0.03 0.00 0.00 
DPA (22:5n-3) 0.03 0.03 0.00 0.00 















Food groups: WF, WinFood; WF-L, WinFood-L; CSB++, corn-soy blend plus plus; CSB+, corn-soy blend plus 
included distributed oil 
2
Refer to Skau et al., (2015) [17]  
3




Calculated from the fatty acid composition of the different food ingredients, which was based on analyses for 
fish (Esomus longimanus, Paralauba typus and mixed batches of small fish), spider (Haplopelma species) and 
database information (frida.fooddata.dk [20]) for the rest of the ingredients. Fat content in CSB+ includes the 
















TABLE 2. Estimated maximum intake of fat and fatty acid from intervention food and the overall contribution of energy from the intervention foods and from 












(n=85) (n=88) (n=83) (n=84) (n=173) (n=167) 
Fatty acid and fat intake (g/day)         
SFA 1.25 ± 0.58 1.13 ± 0.44 0.70 ± 0.32 0.87 ± 0.40 <0.001 1.19 ± 0.51 0.79 ± 0.37 <0.001 
MUFA 1.21 ± 0.56 1.04 ± 0.41 1.15 ± 0.53 1.68 ± 0.73 <0.001 1.13 ± 0.49 1.42 ± 0.69 <0.001 
PUFA 2.03 ± 0.94 2.08 ± 0.81 2.68 ± 1.23 4.26 ± 1.87 <0.001 2.06 ± 0.87 3.47 ± 1.77 <0.001 
n-6 PUFA 1.70 ± 0.78 1.73 ± 0.67 2.38 ± 1.09 4.11 ± 1.80 <0.001 1.71 ± 0.73 3.25 ± 1.72 <0.001 
LA (18:2n-6) 1.61 ± 0.74 1.66 ± 0.65 2.38 ± 1.09 4.10 ± 1.81 <0.001 1.63 ± 0.69 3.25 ± 1.72 <0.001 
AA (20:4n-6) 0.05 ± 0.03 0.03 ± 0.01 0.00 0.00 <0.001 0.04 ± 0.02 0.00 <0.001 
n-3 PUFA 0.32 ± 0.14 0.34 ± 0.13 0.29 ± 0.13 0.16 ± 0.08 <0.001 0.34 ± 0.14 0.22 ± 0.13 <0.001 
ALA (18:3n-3) 0.22 ± 0.10 0.25 ± 0.10 0.29 ± 0.13 0.16 ± 0.07 <0.001 0.24 ± 0.10 0.22 ± 0.12 0.092 
EPA (20:5n-3) 0.03 ± 0.01 0.02 ± 0.01 0.00 0.00 <0.001 0.02 ± 0.01 0.00 <0.001 
DPA (22:5n-3) 0.02 ± 0.01 0.02 ± 0.01 0.00 0.00 <0.001 0.02 ± 0.01 0.00 <0.001 
DHA (22:6n-3) 0.04 ± 0.02 0.05 ± 0.02 0.00 0.00 <0.001 0.05 ± 0.02 0.00 <0.001 
Total fat 5.0 ± 2.3 4.7 ± 1.8 4.9 ± 2.3 7.4 ± 3.2 <0.001 4.9 ± 2.1 6.2 ± 3.0 <0.001 
Energy from intervention food fat 




6.32 ± 23.80 5.8 ± 2.2 6.12 ± 2.76 9.32 ± 34.90 <0.001 6.0 ± 2.56 7.7 ± 3.7 <0.001 














to the daily energy requierement
5
 (%) 
Energy from intervention food fat 




14.2 ± 6.2 13.0 ± 4.7 13.8 ± 5.8 21.0 ± 8.6 <0.001 13.6 ± 5.5 17.4 ± 8.1 <0.001 
Energy from intervention foods relative 




79.2 ± 34.8 74.2 ± 26.5 75.5 ± 31.8 80.4 ± 32.8 0.252 76.7 ± 30.9 78.0 ± 32.3 0.658 
1
Values are mean ± SD for 9 months intervention study, based on the exact number of days of participation from baseline to endline for each child. Food 
groups: WF, WinFood; WF-L, WinFood-L; CSB++, corn-soy-blend plus plus; CSB+, corn-soy-blend plus including the distributed oil. 
2
Compliance data were collected every month for 340 of the 358 infants who completed the study (came to both baseline and endline). Compliance was based 
on amount of food returned to the food distributor every month. The amount of food retained by the participants represents the maximum intake since any 
wasted food after preparation was not registered. 
3
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; LA, linoleic acid; AA, arachidonic acid; ALA, alpha-
linolenic acid; EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid. 
4
P values for difference between groups based on Kruskal-Wallis test. 
5
Daily energy requirement was set at 682 kcal/day, 830 kcal/day and 1092 kcal/day for infants at age groups 6-8, 9-11 months and children age 12-23 months, 
respectively. Daily energy required from complementary food was set at 269 kcal/day, 451 kcal/day, and 746 kcal/day for infants at age groups 6-8, 9-11 



























Table 3. Characteristics of study participants by food group1,2 
 
WF WF-L CSB++ CSB+ 
 
(n=106) (n=104) (n=103) (n=106) 
Boys, n (%) 56 (52.8) 54 (51.9) 54 (52.4) 56 (52.8) 
Age, mo 5.79 ± 0.50 5.95 ± 0.59 5.87 ± 0.53 5.90 ± 0.59 
Anthropometry 
    
Weight, kg 6.89 ± 0.90 6.89 ± 0.84 6.75 ± 0.94 6.82 ± 0.82 
Length, cm 64.4 ± 2.5 64.6 ± 2.3 64.0 ± 2.7 64.4 ± 2.4 
Weight-for-length z score -0.3 ± 1.0 -0.4 ± 0.9 -0.4 ± 1.0 -0.4 ± 0.9 
Infants with z score <-2, n (%) 2 (1.88) 4 (3.85) 7 (6.80) 5 (4.72) 
Length-for-age z score -0.9 ± 1.0 -0.9 ± 1.0 -1.1 ± 1.1 -1.0 ± 0.9 
Infants with z score , <-2, n (%) 13 (12.3) 13 (12.5) 22 (21.4) 14 (13.2) 
Breastfeeding status 
    
Age when stop breastfeeding (%) 14.95 ± 2.32 15.38 ± 1.91 15.40 ± 1.94 15.48 ± 1.47 














Children who were still breastfed at baseline, n (%) 102 (97.1) 101 (98.1) 101 (98.1) 106 (100) 
Children who were still breastfed at endline, n (%) 59 (69.4) 74 (80.4) 70 (79.5) 75 (81.5) 
Biological indicators, n (%)         
Haemoglobin, g/L 10.77 ± 0.99 10.66 ± 0.89 10.80 ± 0.86 10.77 ± 0.92 
CRP median, interquartile range (mg/L) 9.70 (36.97) 9.39 (43.24) 9.46 (20.03) 7.11 ± 29.85 
Infants with CRP < 5 mg/L 36 (35.0) 44 (43.1) 34 (34.0) 37 (37.4) 
Infants with CRP ≥ 5 mg/L 67 (65.1) 58 (56.9) 66 (66.0) 62 (62.6) 
Compliance  
    
Total compliance (kg/9 mo intervention) 14.7 ± 6.8 14.7 ± 6.9 13.8 ± 7.3 13.4 ± 7.4 
Total compliance rate (% of distributed food) 65.2 ± 30.0 65.2 ± 30.5 61.2 ± 32.6 59.5 ± 32.9 
Treat water before drinking, n (%) 
    
Boil or filter 82 (77.4) 73 (70.2) 80 (77.7) 76 (71.7) 
No treatment 22 (20.8) 27 (26.0) 22 (21.4) 27 (25.5) 
Toilet facilities, n (%) 
    
Flush toilet or pit latrine 24 (22.6) 26 (25.0) 22 (21.4) 19 (17.9) 
No toilet/in the nature 80 (75.5) 77 (74.0) 80 (77.7) 84 (79.3) 
Household primary income, n (%) 
    
Labour 18 (17.0) 9 (8.7) 7 (6.8) 15 (14.2) 
Fishery 3 (2.8) 2 (1.9) 6 (5.8) 6 (5.7) 
Farming (incl. livestock owning) 60 (56.6) 63 (60.6) 66 (64.1) 63 (59.4) 
Economic possessions, n (%) 














TV 68 (64.2) 72 (69.2) 71 (68.9) 81 (76.4) 
Mobile phones 61 (57.6) 63 (60.6) 66 (64.1) 75 (70.8) 
Bicycle 78 (73.6) 75 (72.1) 80 (77.7) 74 (69.8) 
Motorcycle 46 (43.4) 48 (46.2) 50 (48.5) 53 (50.0) 
Livestock 78 (73.6) 77 (74.0) 85 (82.5) 87 (82.1) 
Whole blood fatty acid composition (% of fatty acids)3,4 
SFA  45.53 ± 1.85 45.79 ± 1.83 45.45 ± 1.82 45.34 ± 2.06 
MUFA  24.05 ± 2.53 23.95 ± 2.48 24.03 ± 2.59 24.19 ± 2.39 
PUFA 26.73 ± 2.82 26.51 ± 2.53 26.71 ± 2.58 26.73 ± 2.05 
n-6 PUFA  23.10 ± 2.74 22.85 ± 2.27 23.03 ± 2.43 23.13 ± 1.85 
n-3 PUFA 3.62 ± 0.69 3.66 ± 0.60 3.68 ± 0.64 3.60 ± 0.63 
EPA (20:5n-3)  0.21 ± 0.06 0.22 ± 0.07 0.23 ± 0.08 0.21 ± 0.07 
DPA (22:5n-3) 0.53 ± 0.09 0.52 ± 0.10 0.53 ± 0.10 0.51 ± 0.09 
DHA (22:6n-3)  2.71 ± 0.61 2.73 ± 0.52 2.73 ± 0.55 2.69 ± 0.53 
Total fat (µg/dL) 354 ± 91 350 ± 87 353 ± 95 341 ± 83 
2Values are mean ± SD or n (%). Food groups: WF, WinFood; WF-L, WinFood-L; CSB++, corn-soy-blend plus plus; CSB+, corn-soy-blend plus with inclusion of the 
separately distributed oil 
3Out of 419 infants who participated in the study, blood was not taken from 30 infants at baseline, so the baseline data is based on n=389 (WF=98, WF-L=97, CSB++=95, 
CSB+=99). 
3SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; EPA, eicosapentaenoic acid; DPA, Docosapentaenoic acid; DHA, 
docosahexaenoic acid 






































(n=73) (n=80) (n=79) (n=76) (n=153) (n=155) 
SFA (FA%) 43.80 ± 2.01 43.84 ± 1.50 43.64 ± 1.59 43.94 ± 1.95 0.888 43.82 ± 1.75 43.79 ± 1.78 0.936 
MUFA (FA%) 22.25 ± 3.50 21.80 ± 3.31 21.76 ± 3.20 22.10 ± 2.79 0.575 22.02 ± 3.40 21.93 ± 3.00 0.608 
PUFA (FA%) 30.35 ± 3.33 30.75 ± 3.18 30.91 ± 3.08 30.33 ± 3.08 0.433 30.55 ± 3.25 30.62 ± 3.08 0.482 
n-6 PUFA (FA%) 26.12 ± 2.92 26.37 ± 2.70 26.61 ± 2.73 26.05 ± 2.70 0.463 26.25 ± 2.80 26.34 ± 2.72 0.608 
LA (18:2n-6) (FA%) 14.02 ± 2.89 14.00 ± 2.41 14.20 ± 2.57 13.79 ± 2.41 0.805 14.01 ± 2.64 14.00 ± 2.49 0.729 
AA (20:4n-6) (FA%) 9.12 ± 1.86 9.38 ± 1.60 9.50 ± 1.85 9.33 ± 1.70 0.695 9.26 ± 1.73 9.42 ± 1.78 0.915 
n-3 PUFA (FA%) 4.23 ± 0.87 4.38 ± 0.87 4.30 ± 0.90 4.28 ± 0.83 0.689 4.31 ± 0.87 4.29 ± 0.87 0.259 
ALA (18:3n-3) (FA%) 0.18 ± 0.11 0.17 ± 0.08 0.18 ± 0.08 0.16 ± 0.05 0.649
4
 0.18 ± 0.10 0.17 ± 0.07  0.629
4
 
EPA (20:5n-3) (FA%) 0.28 ± 0.10 0.29 ± 0.10 0.31 ± 0.12 0.29 ± 0.10 0.927
5
 0.29 ± 0.10 0.30 ± 0.11  0.634
5
 
DPA (22:5n-3) (FA%) 0.67 ± 0.13 0.68 ± 0.12 0.69 ± 0.13 0.66 ± 0.11 0.543 0.67 ± 0.13 0.68 ± 0.12 0.822 














LCPUFA (FA%) 15.78 ± 2.78 16.21 ± 2.38 16.17 ± 2.77 16.03 ± 2.56 0.777 16.01 ± 2.58 16.10 ± 2.66 0.570 
n-6/n-3 PUFA 6.39 ± 1.25 6.21 ± 1.09 6.46 ± 1.55 6.30 ± 1.26 0.493 6.29 ± 1.17 6.38 ± 1.41  0.301
5
 
n-3 LCPUFA (%) 25.55 ± 2.72 25.84 ± 3.05 25.34 ± 3.03 25.56 ± 2.62 0.542 25.70 ± 2.89 25.44 ± 2.83 0.278 
Total fatty acid (µg/L) 334 ± 63 333 ± 52 338 ± 56 339 ± 68 0.927 335 ± 58 338 ± 62 0.696 
1
Values are mean ± SD. P values for difference between groups from ANCOVA of the endline values with baseline values, sex, age, age when stop 
breastfeeding, age when starting complementary food, breastfeeding status in the last 24 hours at endline, and baseline CRP values as covariates 
2
Of the 419 infants enrolled in the study, complete data for endline whole blood fat and covariates were available from 308 infants 
3
 FA%, % of all fatty acids; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; LA, linoleic acid; AA, 
arachidonic acid; ALA, alpha-linolenic acid; EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; LCPUFA, long-chain 
unsaturated fatty acid (≥20C and ≥3 double bonds); n-3 LCPUFA, % of n-3 LCPUFA among total LCPUFA 
4
P-value is based on analysis of log-transformed data 
5














TABLE 5. Whole blood fatty acid composition and total fatty acids after 9 months of intervention with food with 




All respondents Breastfed at endline 

















based  P 














































































































































































































































































































































Values are mean ± SD. P values for difference between groups from ANCOVA of the endline values, with baseline 
















Breastfeeding in the last 24 hours was successfully measured at endline in 357 infants, of whom 278 were 
breastfed, and 79 were not breastfed in the last 24 hours. The final number of respondents with covariate 
information was 306; hereof 237 who were breastfed and 69 who were not breastfed in the last 24 hours at endline. 
3
FA%, % of all fatty acids; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated 
fatty acids; LA, linoleic acid; AA, arachidonic acid; ALA, alpha-linolenic acid; EPA, eicosapentaenoic acid; DPA, 
docosapentaenoic acid; DHA, docosahexaenoic acid; LCPUFA, long-chain unsaturated fatty acid (≥20C and ≥3 
double bonds); n-3 LCPUFA, % of n-3 LCPUFA among total LCPUFA.  
4
Data were inverse square root transformed to create normal distribution for the statistical analysis. 
5
Data were square root transformed to create normal distribution for the statistical analysis. 
6
















































CSB+, blood was 
successfully 
withdrawn from 




CSB++, blood was 
successfully 
withdrawn from 
95 infants.  
 
21 left study 
area 
14 left study 
area 
14 left study area, 









10 left study 
area, 1 died in 
accident 
92 completed the 











88 completed the 
study, 84 of 
whom consumed 
the intervention 
food. Blood were 
successfully 
withdrawn from 





93 completed the 











85 completed the 
study, all consumed 
the intervention 
food. Blood were 
successfully 
withdrawn from 81 








WF, blood was 
successfully 
withdrawn from 
98 infants.  
21 excluded  
 3 severe anaemic 
 4 WLZ<-3 
 4 twins 
 10 with chronic diseases Screening (n=440) 
Invited (n=514) 
 
Randomization, (n=419) 
Dropouts (n=61) 
 
Endline (n=341) 
